• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

六氯环己烷对大鼠红细胞膜和脑组织中磷酸肌醇的影响。

Influence of hexachlorocyclohexane on phosphoinositides in rat erythrocyte membranes and brain.

作者信息

Agrawal D, Subramoniam A, Afaq F

机构信息

Industrial Toxicology Research Centre, Lucknow, India.

出版信息

Toxicology. 1995 Jan 6;95(1-3):135-40. doi: 10.1016/0300-483x(94)02898-5.

DOI:10.1016/0300-483x(94)02898-5
PMID:7529952
Abstract

Single exposure of rats to hexachlorocyclohexane (100 mg/kg) did not cause any significant change in phosphoinositide levels in rat erythrocyte membrane and cerebrum (fore brain) 2 or 24 h after exposure. However, the phosphoinositide turnover and generation of second messengers from phosphoinositides were increased in the treated erythrocyte membranes as judged from a marked increase in the incorporation of [2-3H]inositol into phosphoinositides 24 h after the treatment. A significant decrease in phosphatidylinositol (PI), phosphatidylinositol 4-phosphate (PIP) and phosphatidylinositol 4,5-bisphosphate (PIP2) was observed in the erythrocyte membrane and cerebrum of rats repeatedly exposed to the pesticide for 3 or 6 months. This drastic reduction in phosphoinositide levels suggests adverse effects on vital membrane and cell functions modulated by phosphoinositides.

摘要

大鼠单次暴露于六氯环己烷(100毫克/千克)后,在暴露后2小时或24小时,大鼠红细胞膜和大脑(前脑)中的磷酸肌醇水平未发生任何显著变化。然而,从处理后24小时[2-3H]肌醇掺入磷酸肌醇的显著增加判断,处理后的红细胞膜中磷酸肌醇周转率和磷酸肌醇产生的第二信使增加。在反复接触该农药3个月或6个月的大鼠的红细胞膜和大脑中,观察到磷脂酰肌醇(PI)、磷脂酰肌醇4-磷酸(PIP)和磷脂酰肌醇4,5-二磷酸(PIP2)显著减少。磷酸肌醇水平的这种急剧下降表明对由磷酸肌醇调节的重要膜和细胞功能产生了不利影响。

相似文献

1
Influence of hexachlorocyclohexane on phosphoinositides in rat erythrocyte membranes and brain.六氯环己烷对大鼠红细胞膜和脑组织中磷酸肌醇的影响。
Toxicology. 1995 Jan 6;95(1-3):135-40. doi: 10.1016/0300-483x(94)02898-5.
2
[3H]Inositol incorporation into phosphoinositides of pig reticulocytes.
Biochim Biophys Acta. 1985 Dec 5;821(2):305-9. doi: 10.1016/0005-2736(85)90100-2.
3
Influence of stress on phosphoinositides in rat brain.应激对大鼠脑内磷酸肌醇的影响。
Neurosci Lett. 1990 Feb 16;109(3):331-4. doi: 10.1016/0304-3940(90)90017-4.
4
Asymmetric distribution of phosphoinositides and phosphatidic acid in the human erythrocyte membrane.
Biochim Biophys Acta. 1991 Oct 14;1069(1):27-36. doi: 10.1016/0005-2736(91)90100-m.
5
Differences in the metabolism of inositol and phosphoinositides by cultured cells of neuronal and glial origin.源自神经元和神经胶质的培养细胞对肌醇和磷酸肌醇代谢的差异。
Biochim Biophys Acta. 1989 Aug 8;1004(2):169-79. doi: 10.1016/0005-2760(89)90265-8.
6
Early effects of luteinizing hormone on mitochondrial phosphoinositides in ovarian follicles.促黄体生成素对卵泡线粒体磷酸肌醇的早期作用。
Biol Reprod. 1987 Feb;36(1):97-102. doi: 10.1095/biolreprod36.1.97.
7
Phosphoinositide turnover in erythrocyte membranes in human and experimental hypertension.人类和实验性高血压中红细胞膜的磷酸肌醇转换
J Hypertens. 1985 Feb;3(1):25-30. doi: 10.1097/00004872-198502000-00005.
8
Influence of trichloroethylene treatment on phosphoinositides in rat brain.
Toxicol Lett. 1989 Oct;49(1):55-60. doi: 10.1016/0378-4274(89)90101-x.
9
Glycerol-3-phospho-D-myo-inositol 4-phosphate (Gro-PIP) is an inhibitor of phosphoinositide-specific phospholipase C.甘油-3-磷酸-D-肌醇4-磷酸(Gro-PIP)是一种磷酸肌醇特异性磷脂酶C的抑制剂。
Biochim Biophys Acta. 1990 Jan 16;1042(1):113-8. doi: 10.1016/0005-2760(90)90064-5.
10
Phosphoinositide hydrolysis by guanosine 5'-[gamma-thio]triphosphate-activated phospholipase C of turkey erythrocyte membranes.火鸡红细胞膜中由鸟苷5'-[γ-硫代]三磷酸激活的磷脂酶C引起的磷酸肌醇水解作用。
Biochem J. 1988 Jun 1;252(2):583-93. doi: 10.1042/bj2520583.

引用本文的文献

1
Does lindane (gamma-hexachlorocyclohexane) increase the rapid delayed rectifier outward K+ current (IKr) in frog atrial myocytes?林丹(γ-六氯环己烷)是否会增加青蛙心房肌细胞中的快速延迟整流外向钾电流(IKr)?
BMC Pharmacol. 2002 Jul 10;2:15. doi: 10.1186/1471-2210-2-15.